Bone Cancer News

Denosumab Active Against Giant Cell Tumor of Bone (February 11, 2010)

In a Phase II clinical trial, denosumab produced high rates of tumor response among patients with recurrent or unresectable giant cell tumors of bone. These results were published in Lancet Oncology. Denosumab is an investigational drug that targets... Continue Reading

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone (June 5, 2009)

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone In a Phase II clinical trial, 86% of patients with giant cell tumor of the bone responded to treatment with the investigational targeted therapy denosumab. These results were presented... Continue Reading

Latest Bone Cancer News By Stage

General Bone Cancer

Denosumab Active Against Giant Cell Tumor of Bone (February 11, 2010)

In a Phase II clinical trial, denosumab produced high rates of tumor response among patients with recurrent or unresectable giant cell tumors of bone. These results were published in Lancet Oncology. Denosumab is an investigational drug that targets... Continue Reading

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone (June 5, 2009)

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone In a Phase II clinical trial, 86% of patients with giant cell tumor of the bone responded to treatment with the investigational targeted therapy denosumab. These results were presented... Continue Reading

Denosumab Reduces the Risk of Bone Fractures (March 8, 2009)

Denosumab Reduces the Risk of Bone Fractures According to the results of a Phase III clinical trial, treatment with denosumab significantly reduces the risk of vertebral and hip fractures among postmenopausal women with osteoporosis. These results were... Continue Reading

More General Bone Cancer